Our Products
We are leaders in the market for providing best range of Brigatinib, Lenvima, Cjc 1295-DAC, Sapropterin and Cyclophosphamide
Lenvima 24mg
Lenvima (lenvatinib) is a receptor tyrosine kinase (RTK) inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4).
Lenvima is specifically indicated for use in combination with everolimus for the treatment of patients with advanced RCC following one prior anti-angiogenic therapy.
PLEASE CONTACT US ON EMAL DIRECTLY FOR FAST RESPONSE
Additional Information:
Payment Terms : T/T, Western Union
Packaging Details : BUBBLE WRAPPED
Delivery Time : 7 DAYS